Severe Hemophilia A Withdrawn Phase Trials for Moroctocog alfa (DB13999)

Also known as: Severe Haemophilia A / Hemophilia A, Severe

IndicationStatusPhase
DBCOND0034640 (Severe Hemophilia A)WithdrawnNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01051544Study of First TIME Immunotolerance Induction in Severe Hemophilia A Patients With Inhibitor at High Risk of Failure: Comparison With FVIII Concentrates With or Without Von Willebrand Factor - RES.I.S.T. NaivePrevention